UNITY BIOTECHNOLOGY INC (UBX) Stock Income Statement
NASDAQ:UBX - Nasdaq - US91381U2006 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 236.00K | 4.78M | 0.00 | |||
| Operating Expenses | 28.47M | 38.47M | 55.91M | 61.45M | 91.30M | |||
| Research and Development | 13.01M | 19.70M | 35.46M | 38.39M | 67.31M | |||
| Selling, General, and Administrative Expenses | 15.46M | 18.77M | 20.45M | 23.06M | 24.02M | |||
| Operating Income | -28.47M | -38.47M | -55.67M | -56.66M | -91.30M | |||
| Interest Income/Expense | 1.73M | 422.00K | -2.34M | -3.08M | -96.00K | |||
| Other Income/Expense | 3.45M | 4.88M | 15.24M | -1.18M | 182.00K | |||
| Non Recurring Items | -2.71M | -6.70M | -1.70M | 200.00K | -2.63M | |||
| Income Before Taxes | -25.99M | -39.86M | -44.47M | -60.73M | -93.84M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -25.99M | -39.86M | -44.47M | -60.73M | -93.84M | |||
| EBITDA | -27.60M | -37.28M | -53.49M | -53.78M | -87.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.54 | -2.70 | -4.68 | -10.88 | -18.45 | |||
| Non GAAP EPS | -1.53 | -2.55 | -7.06 | -10.90 | -18.10 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -18842.80% | -1269.34% | N/A | |||
| Operating Profit Margin | N/A | N/A | -23589.83% | -1184.47% | N/A | |||
All data in USD